Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol

@article{JazayeriTehrani2017EfficacyON,
  title={Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol},
  author={Seyed Ali Jazayeri-Tehrani and Seyed Mahdi Rezayat and Siavash Mansouri and Mostafa Qorbani and Seyed Moayed Alavian and Milad Daneshi-Maskooni and Mohammad Javad Hosseinzadeh‐Attar},
  journal={BMJ Open},
  year={2017},
  volume={7}
}
Objectives Different studies have been conducted on the role of curcumin in health since having multiple properties, including antioxidant and anti-inflammatory effects. Due to the lack of studies regarding curcumin effects on obese patients with non-alcoholic fatty liver disease (NAFLD), our protocol was designed to assess nanocurcumin impacts on blood sugar, lipids, inflammatory indices, insulin resistance and liver function, especially by nesfatin. Setting This trial will be conducted in the… 
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
TLDR
NC supplementation in overweight/obese NAFLD patients improved glucose indices, lipids, inflammation, WC, nesfatin, liver transaminases, and fatty liver degree, and the proposed mechanism for amelioratingNAFLD with NC was approved by the increased serum nesFatin and likely consequent improvements in inflammation,lipids, and glucose profile.
The Nanocurcumin Reduces Appetite in Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Double-Blind Randomized Placebo-Controlled Clinical Trial
TLDR
Overall results showed the nanocurcumin supplementation reduced appetite significantly, however, determining the potential role of curcumin in managing of NAFLD- and obesity-related conditions need further study.
Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
TLDR
GC supplementation could improve some biomarkers related to fatty liver including inflammation, ALT, and Sirt1 in overweight/obese NAFLD patients.
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
TLDR
GC supplement improved the grade of fatty liver, serum glucose indices, lipids, and irisin level among overweight or obese NAFLD patients, and the changes in these biomarkers may yield beneficial effects onNAFLD.
Does Turmeric/curcumin Supplementation Change Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis of Randomized Controlled Trials
TLDR
Meta-analysis showed that turmeric/curcumin supplementation had no significant effect on body weight, BMI and WC in patients with NAFLD, and further studies with large-scale are needed to find out possible anti-obesity effects.
The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials
TLDR
Curcumin is effective in lowering LDL-C, triglycerides, FBS, HOMA-IR, weight, and AST levels in NAFLD patients, and it is well tolerated.
Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta‐analysis of randomized controlled trials
TLDR
It is suggested that turmeric/curcumin might have a favorable effect on serum concentrations of ALT and AST in patients with NAFLD, however, further clinical trials are needed to confirm these findings.
Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats
  • P. Cui, Wei Hu, Yi Feng
  • Biology, Medicine
    The Journal of Steroid Biochemistry and Molecular Biology
  • 2021
The Effect of Curcumin Supplementation on Anthropometric Measures among Overweight or Obese Adults
TLDR
The aim of this review is to evaluate the effect of curcumin supplementation on the anthropometric indices among overweight or obese adults and to explore the effects of certain herbs or dietary spices on obesity.
...
...

References

SHOWING 1-10 OF 55 REFERENCES
Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease.
  • A. Sahebkar
  • Biology
    World journal of gastroenterology
  • 2011
TLDR
Ginger has been hypothesized to prevent NAFLD or blunt its progression via several mechanisms, such as sensitizing insulin effects, activating peroxisome proliferator-activated receptor γ which induces adiponectin and down-regulates pro-inflammatory cytokines.
Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
AIM To investigate the relationship between the gut-liver axis and nonalcoholic fatty liver disease (NAFLD), we performed a meta-analysis to evaluate the effects of probiotic therapy in NAFLD.
Effect of Oral Curcumin Administration on Insulin Resistance, Serum Resistin and Fetuin-A in Obese Children: Randomized Placebo-Controlled Study
TLDR
Short-term curcumin supplementation in obese children could decrease insulin resistance through reduction of high level of serum resistin and fetuin-A.
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
TLDR
In non-obese NAFLD patients, intakes of total energy and carbohydrates were not excessive, although dietary cholesterol was superabundant and dietary PUFAs were significantly lower compared with those in obese patients; and characteristic fat intake may be associated with the formation ofNAFLD.
Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.
TLDR
The purpose of this review is to explore the existing evidences on dietary supplements considered to have hepatoprotective properties, and to present some proposed mechanisms by which they may protect against NAFLD.
A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease
TLDR
The results of this study indicate that nesfatin-1 may have a significant role in non-alcoholic fatty liver disease (NAFLD), and a negative correlation between nesFatin- 1 and fasting glucose and body mass index is found.
Diets and nonalcoholic fatty liver disease: the good and the bad.
Investigation of the Effects of Curcumin on Serum Cytokines in Obese Individuals: A Randomized Controlled Trial
TLDR
The findings of the present trial suggested that curcumin may exert immunomodulatory effects via altering the circulating concentrations of IL-1β, IL-4, and VEGF.
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.
TLDR
Patients with nonalcoholic fatty liver disease should optimally achieve a 5%-10% weight reduction and PA should be integrated into behavioral therapy in NAFLD, as even small gains in PA and fitness may have significant health benefits.
A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications
TLDR
Curcumin supplementation effectively mitigates inflammation in patients suffering from chronic SM-induced cutaneous complications and might account for the observed pruritus alleviation and QoL improvement by this phytochemical.
...
...